QNRF and QGP Announce PPM4 Awardees
/ Categories: Announcements

QNRF and QGP Announce PPM4 Awardees

As part of its efforts to support and advance Qatar’s precision medicine and genomic research infrastructure, Qatar National Research Fund (QNRF) and Qatar Genome Program (QGP) are delighted to announce the results for the fourth cycle of the Path towards Precision Medicine (PPM) call. The PPM aims to promote research that provides tailored medical treatment catering to the individual characteristics of each patient in Qatar based on their genetic profile, and to improve the care quality while reducing unnecessary diagnostic testing and therapies.

In this cycle, 30 research proposals were received and were subjected to a competitive and thorough evaluation process. Out of these, five outstanding projects have been awarded to receive grants of up to USD 700,000 for a period of up to 4 years.

QNRF established the PPM call in collaboration with the Qatar Genome Programme (QGP) to capitalize on the wealth of data generated by QGP and to support the vision of making Qatar a pioneer in the field of genomic medicine research. For the fourth cycle of PPM, researchers were invited to apply for the following four priority areas:

  1. Immunogenomics and precision immunotherapeutic approaches
  2. Clinical implementation of pharmacogenomics
  3. Multi-omics analysis of common chronic diseases such as cardiovascular diseases, neurological disorders, and cancer
  4. Precision medicine digital e-solutions and applications

Please browse through the list below to learn more about the awarded research projects.

Proposal Number


Submitting Institution


PPM 04-0128-200014

`Pharmacogenetics in childhood acute lymphoblastic leukemia: from variants identification to clinical implementation

Sidra Medicine


PPM 04-0131-200019

Early diagnosis of proteinopathies using massively parallel nano-spectroscopy with single-molecule sensitivity. Advanced clinical diagnostics for the development of personalized treatments

Texas A&M University at Qatar

Prof. Milivoj Belic

PPM 04-0311-200035

Exploring Drug Resistance Mechanisms in Triple Negative Breast Cancers: From Patient Derived Organoids towards Precision Medicine

Weill Cornell Medical College in Qatar

Prof. Lotfi Chouchane

PPM 04-0312-200037

Pharmacogenomics of TNF inhibitors in autoimmune diseases

Hamad Bin Khalifa University

Dr. Borbala Mifsud

PPM 04-0128-200015

Unlocking precision medicine potential through functional genomic studies in the diagnosis of inherited immunodeficiency diseases

Sidra Medicine

Dr. Amel Hassan



Previous Article Record number of 17 HBKU-CSE students win QNRF’s prestigious GSRA scholarships
Next Article Results for OSRA5 Announced
«December 2022»